DaVita HealthCare Partners Inc. (NYSE:DVA) – SunTrust Banks issued their Q1 2019 earnings per share (EPS) estimates for DaVita HealthCare Partners in a note issued to investors on Thursday. SunTrust Banks analyst D. Macdonald forecasts that the company will post earnings per share of $0.92 for the quarter. SunTrust Banks also issued estimates for DaVita HealthCare Partners’ Q2 2019 earnings at $1.08 EPS.

DaVita HealthCare Partners (NYSE:DVA) last issued its quarterly earnings data on Tuesday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.02. DaVita HealthCare Partners had a return on equity of 14.02% and a net margin of 8.68%. The firm had revenue of $3.88 billion for the quarter, compared to analyst estimates of $3.82 billion. During the same period in the prior year, the firm posted $1.01 EPS. The company’s revenue for the quarter was up 4.3% on a year-over-year basis.

ILLEGAL ACTIVITY NOTICE: This story was originally published by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at https://www.dailypolitical.com/2017/09/20/davita-healthcare-partners-inc-to-post-q1-2019-earnings-of-0-92-per-share-suntrust-banks-forecasts-dva.html.

Other analysts have also issued reports about the company. Jefferies Group LLC set a $70.00 target price on DaVita HealthCare Partners and gave the company a “buy” rating in a research note on Friday, May 26th. TheStreet lowered DaVita HealthCare Partners from a “b” rating to a “c+” rating in a research note on Wednesday, August 2nd. Royal Bank Of Canada restated a “hold” rating and issued a $64.00 target price on shares of DaVita HealthCare Partners in a research note on Wednesday, September 6th. Zacks Investment Research upgraded DaVita HealthCare Partners from a “sell” rating to a “hold” rating in a research note on Thursday, August 3rd. Finally, BidaskClub lowered DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a research note on Saturday, July 8th. Two analysts have rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $68.88.

Shares of DaVita HealthCare Partners (DVA) traded up 1.33% on Monday, reaching $60.07. The company’s stock had a trading volume of 715,452 shares. DaVita HealthCare Partners has a 52-week low of $54.50 and a 52-week high of $70.16. The firm’s 50 day moving average is $57.94 and its 200-day moving average is $64.11. The stock has a market cap of $11.49 billion, a P/E ratio of 9.15 and a beta of 0.91.

Several hedge funds and other institutional investors have recently made changes to their positions in DVA. Profund Advisors LLC grew its position in shares of DaVita HealthCare Partners by 4.7% in the first quarter. Profund Advisors LLC now owns 6,328 shares of the company’s stock valued at $430,000 after purchasing an additional 282 shares in the last quarter. UBS Asset Management Americas Inc. grew its position in shares of DaVita HealthCare Partners by 5.4% in the first quarter. UBS Asset Management Americas Inc. now owns 695,579 shares of the company’s stock valued at $47,279,000 after purchasing an additional 35,542 shares in the last quarter. Gamco Investors INC. ET AL grew its position in shares of DaVita HealthCare Partners by 2.3% in the first quarter. Gamco Investors INC. ET AL now owns 22,163 shares of the company’s stock valued at $1,506,000 after purchasing an additional 500 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in shares of DaVita HealthCare Partners by 27.6% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 11,548 shares of the company’s stock valued at $785,000 after purchasing an additional 2,495 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its position in shares of DaVita HealthCare Partners by 29.6% in the first quarter. Ameriprise Financial Inc. now owns 150,261 shares of the company’s stock valued at $10,213,000 after purchasing an additional 34,341 shares in the last quarter. Institutional investors own 83.31% of the company’s stock.

About DaVita HealthCare Partners

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Earnings History and Estimates for DaVita HealthCare Partners (NYSE:DVA)

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.